SL Swiss Lipid Navigator
Demonstration prototype — synthetic data only, simplified rules, not for clinical use.
Step 10 of 10 · Decision support

Summary

What this step shows

All results for this patient in one view, with the reasoning behind each step. Update any value and the results are recalculated.

Thomas Keller
DEMO-1 · 58 years · Male · born 26.05.1968 · LDL-C measured 28.08.2026
Update lab values
Clinical pathwayPrimary Prevention — Standard pathway
Risk categoryHigh
LDL-C (current)3.8 mmol/L
LDL-C target<1.8 mmol/L
Current treatmentNo statin
Recommended next stepInitiate high-intensity statin
Swiss reimbursement Not applicable at this stage
Reasoning by step
  1. Step 5 — Clinical pathway View details →
    Primary Prevention — Standard pathway

    No CVD, no FH, no diabetes, under 65: standard primary-prevention risk methodology applies.

  2. Step 6 — Cardiovascular risk View details →
    High

    Simplified demo scoring (age + smoking + blood pressure + baseline LDL-C) → 5 points → High risk. This is illustrative only, not the licensed ESC calculator.

  3. Step 7 — LDL-C target View details →
    <1.8 mmol/L

    High risk → target <1.8 mmol/L.

  4. Step 8 — Treatment plan View details →
    Initiate high-intensity statin

    No lipid-lowering therapy on file yet and no intolerance recorded — start with a high-intensity statin.

  5. Step 9 — Swiss reimbursement View details →
    Not applicable at this stage

    This engine only activates once a PCSK9 inhibitor (or another reimbursement-restricted therapy) is clinically proposed. For this patient, the Treatment Engine recommended a different next step, so no reimbursement check is needed yet.

Demonstration output based on simplified rules — not clinical advice. Generated 02.11.2026 18:25.

← Swiss reimbursement
Back to patients →